Related references
Note: Only part of the references are listed.Ordering Knowledge in the Markers of Psychiatric/Mental Disorders
Napoleon Waszkiewicz
JOURNAL OF CLINICAL MEDICINE (2022)
The clinical characterization of the patient with primary psychosis aimed at personalization of management
Mario Maj et al.
WORLD PSYCHIATRY (2021)
Longitudinal Structural MRI Findings in Individuals at Genetic and Clinical High Risk for Psychosis: A Systematic Review
Kate Merritt et al.
FRONTIERS IN PSYCHIATRY (2021)
Structural and functional imaging markers for susceptibility to psychosis
Christina Andreou et al.
MOLECULAR PSYCHIATRY (2020)
Schizophrenia as parasitic behavior manipulation: can we put together the pieces of an evolutionary puzzle?
Martin Bruene
WORLD PSYCHIATRY (2020)
A neuroimaging biomarker for striatal dysfunction in schizophrenia
Ang Li et al.
NATURE MEDICINE (2020)
Schizophrenia and Sex Hormones: What Is the Link?
Noa A. Brzezinski-Sinai et al.
FRONTIERS IN PSYCHIATRY (2020)
Mentally Sick or Not-(Bio)Markers of Psychiatric Disorders Needed
Napoleon Waszkiewicz
JOURNAL OF CLINICAL MEDICINE (2020)
The evolution of Kraepelin's nosological principles
Stephan Heckers et al.
WORLD PSYCHIATRY (2020)
Metabolomics approach revealed robust changes in amino acid and biogenic amine signatures in patients with schizophrenia in the early course of the disease
Madis Parksepp et al.
SCIENTIFIC REPORTS (2020)
Brain-derived neurotrophic factor (BDNF) levels in first-episode schizophrenia and healthy controls: A comparative study
Jawahar Singh et al.
ASIAN JOURNAL OF PSYCHIATRY (2020)
Aberrant Middle Prefrontal-Motor Cortex Connectivity Mediates Motor Inhibitory Biomarker in Schizophrenia
Xiaoming Du et al.
BIOLOGICAL PSYCHIATRY (2019)
Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models
Toby Pillinger et al.
MOLECULAR PSYCHIATRY (2019)
Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis
Sonja Orlovska-Waast et al.
MOLECULAR PSYCHIATRY (2019)
Saccadic eye movements in different dimensions of schizophrenia and in clinical high-risk state for psychosis
Ilya Obyedkov et al.
BMC PSYCHIATRY (2019)
Differential gene expression analysis in blood of first episode psychosis patients
Daniel J. Leirer et al.
SCHIZOPHRENIA RESEARCH (2019)
Machine learning identifies unaffected first-degree relatives with functional network patterns and cognitive impairment similar to those of schizophrenia patients
Rixing Jing et al.
HUMAN BRAIN MAPPING (2019)
Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis
Emre Bora
PSYCHOLOGICAL MEDICINE (2019)
Network functional connectivity analysis in individuals at ultrahigh risk for psychosis and patients with schizophrenia
Chen Xiongying et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2019)
Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses
Ning Yuan et al.
TRANSLATIONAL PSYCHIATRY (2019)
Neuroinflammation in schizophrenia: meta-analysis of in vivo microglial imaging studies
Tiago Reis Marques et al.
PSYCHOLOGICAL MEDICINE (2019)
Multisite Machine Learning Analysis Provides a Robust Structural Imaging Signature of Schizophrenia Detectable Across Diverse Patient Populations and Within Individuals
Martin Rozycki et al.
SCHIZOPHRENIA BULLETIN (2018)
Resting-State Connectivity Biomarkers of Cognitive Performance and Social Function in Individuals With Schizophrenia Spectrum Disorder and Healthy Control Subjects
Joseph D. Viviano et al.
BIOLOGICAL PSYCHIATRY (2018)
Platform for systems medicine research and diagnostic applications in psychotic disorders-The METSY project
Elisabeth Frank et al.
EUROPEAN PSYCHIATRY (2018)
Combining multi-modality data for searching biomarkers in schizophrenia
Shuixia Guo et al.
PLOS ONE (2018)
Hyperprolactinemia and insulin resistance in drug naive patients with early onset first episode psychosis
Maria Giuseppina Petruzzelli et al.
BMC PSYCHIATRY (2018)
A systematic review of metabolite biomarkers of schizophrenia
Jennifer Davison et al.
SCHIZOPHRENIA RESEARCH (2018)
Multimodal neuromarkers in schizophrenia via cognition-guided MRI fusion
Jing Sui et al.
NATURE COMMUNICATIONS (2018)
Theranostic Biomarkers for Schizophrenia
Matea Nikolac Perkovic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Building better biomarkers: brain models in translational neuroimaging
Choong-Wan Woo et al.
NATURE NEUROSCIENCE (2017)
Saccadic eye movements as markers of schizophrenia spectrum: Exploration in at-risk mental states
Simona Caldani et al.
SCHIZOPHRENIA RESEARCH (2017)
Does neuroimaging have a role in predicting outcomes in psychosis?
Philip McGuire et al.
WORLD PSYCHIATRY (2017)
Brain Structure Biomarkers in the Psychosis Biotypes: Findings From the Bipolar-Schizophrenia Network for Intermediate Phenotypes
Elena I. Ivleva et al.
BIOLOGICAL PSYCHIATRY (2017)
Structural brain changes in schizophrenia at different stages of the illness: A selective review of longitudinal magnetic resonance imaging studies
Bruno Dietsche et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2017)
Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers
Brett A. Clementz et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Cortisol awakening response in patients with psychosis: Systematic review and meta-analysis
Maximus Berger et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
Sex differences in morning cortisol in youth at ultra-high-risk for psychosis
Emily E. Carol et al.
PSYCHONEUROENDOCRINOLOGY (2016)
Prolactin concentrations in antipsychotic-naive patients with schizophrenia and related disorders: A meta-analysis
Leticia Gonzalez-Blanco et al.
SCHIZOPHRENIA RESEARCH (2016)
Nature of Glutamate Alterations in Schizophrenia A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies
Kate Merritt et al.
JAMA PSYCHIATRY (2016)
Brain-imaging studies of treatment-resistant schizophrenia: a systematic review
Elias Mouchlianitis et al.
LANCET PSYCHIATRY (2016)
Glutamate and dopamine in schizophrenia: An update for the 21st century
Oliver Howes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Clinically meaningful biomarkers for psychosis: A systematic and quantitative review
Diana Prata et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2014)
Applications of blood-based protein biomarker strategies in the study of psychiatric disorders
Man K. Chan et al.
PROGRESS IN NEUROBIOLOGY (2014)
A Disrupted-in-Schizophrenia 1 Gene Variant is Associated with Clinical Symptomatology in Patients with First-Episode Psychosis
Javier Vazquez-Bourgon et al.
PSYCHIATRY INVESTIGATION (2014)
Biomarkers for Psychiatric Disorders: Where Are We Standing?
Daniel Martins-de-Souza
DISEASE MARKERS (2013)
Biomarkers in Schizophrenia: A Brief Conceptual Consideration
Cynthia S. Weickert et al.
DISEASE MARKERS (2013)
Neuroinflammation and psychiatric illness
Souhel Najjar et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Cortex Morphology in First-Episode Psychosis Patients With Neurological Soft Signs
Olivier Gay et al.
SCHIZOPHRENIA BULLETIN (2013)
Proton Magnetic Resonance Spectroscopy and Illness Stage in Schizophrenia-A Systematic Review and Meta-Analysis
Stefan Brugger et al.
BIOLOGICAL PSYCHIATRY (2011)
Neurodevelopmental hypothesis of schizophrenia
Michael J. Owen et al.
BRITISH JOURNAL OF PSYCHIATRY (2011)
Candidate Gene Analysis Identifies a Polymorphism in HLA-DQB1 Associated With Clozapine-Induced Agranulocytosis
Maria C. Athanasiou et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis
M. J. Green et al.
MOLECULAR PSYCHIATRY (2011)
Potential therapeutic uses of BDNF in neurological and psychiatric disorders
Alan H. Nagahara et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
DISC1 association, heterogeneity and interplay in schizophrenia and bipolar disorder
W. Hennah et al.
MOLECULAR PSYCHIATRY (2009)
Eye movement dysfunction in first-degree relatives of patients with schizophrenia: A meta-analytic evaluation of candidate endophenotypes
Monica E. Calkins et al.
BRAIN AND COGNITION (2008)
Peripheral Amino Acid Levels in Schizophrenia and Antipsychotic Treatment
Vincenzo De Luca et al.
PSYCHIATRY INVESTIGATION (2008)
Neurological soft signs and schizophrenia: a review of current knowledge
M. -O. Krebs et al.
REVUE NEUROLOGIQUE (2007)
Significance and meaning of neurological signs in schizophrenia: Two decades later
I Bombin et al.
SCHIZOPHRENIA BULLETIN (2005)
Neurological soft-signs and minor physical anomalies in schizophrenia: differential transmission within families
D Gourion et al.
SCHIZOPHRENIA RESEARCH (2003)
The endophenotype concept in psychiatry: Etymology and strategic intentions
II Gottesman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Validation and factorial structure of a standardized neurological examination assessing neurological soft signs in schizophrenia
MO Krebs et al.
SCHIZOPHRENIA RESEARCH (2000)
Share Paper
